SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Acquisition

3 Aug 2012 07:00

RNS Number : 2177J
Ebiquity PLC
03 August 2012
Β 

ο»Ώ

Ebiquity plc

("Ebiquity" or the "Company")

Β 

Acquisition of FirmDecisions

Β 

Ebiquity plc is pleased to announce the acquisition of the entire issued share capital of FirmDecisions ASJP Group Limited, the holding company of the FirmDecisions group ("FirmDecisions" or the "Acquisition"). FirmDecisions is being acquired for an initial consideration of Β£1m which is being satisfied from existing banking facilities. The maximum total consideration is up to Β£7m, payable in cash, depending on the performance of the FirmDecisions business in the three financial years ending 30 April 2014. The Acquisition will be earnings enhancing in the first full financial year.

Β 

FirmDecisions specialises in media and production cost auditing, with specific reference to the advertiser supply chain. FirmDecisions ensures that its advertiser clients benefit from contractual compliance by their agencies and transparency of transactional value.

Β 

FirmDecisions is being acquired from its current and previous managers, including Stephen Broderick, one of FirmDecisions' founders, who will remain as Chief Executive of the FirmDecisions business.

Β 

FirmDecisions' unaudited revenue for the year ended 30 June 2012 was approximately Β£2m and it generated an operating profit before highlighted items of approximately Β£0.3m. FirmDecisions employs approximately 20 people.

Β 

3rd August 2012

Michael Greenlees, Chief Executive Officer of Ebiquity:

Β 

"FirmDecisions is the first name in media financial compliance with experience across a wide range of global clients. This acquisition enables Ebiquity to bring increased transparency to the media transaction market-place and a higher level of advertiser confidence in contractual compliance."

Β 

Enquiries:

Β 

Ebiquity Plc

Β Michael Greenlees, Chief Executive Officer

Β Andrew Beach, Chief Financial Officer

Β 

Tel. +44 (0)20 7650 9600

Numis Securities Limited

Β Lorna Tilbian/Nick Westlake (Financial Adviser and Nominated Adviser)

Β David Poutney (Corporate Broking)

Β 

Tel. +44 (0)20 7260 1000

College Hill

Β Matthew Smallwood

Β Jamie Ramsay

Tel. +44 (0)20 7457 2020

Β 

Numis, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is the Company's nominated adviser and broker. Numis' responsibilities as the Company's nominated adviser under the AIM Rules are owed solely to the London Stock Exchange and are not owed to the Company or to any Director or to any other person. Numis is acting exclusively for the Company in relation to the matters, transactions and arrangements detailed in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the content of this announcement or any matter, transaction or arrangement discussed or referred to in it.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQSSEFWEFESELA
Date   Source Headline
28th May 20265:04 pmRNSResult of AGM
1st May 20261:15 pmRNSNotice of ARA and AGM
27th Apr 202611:42 amRNSNotification of Major Holdings
21st Apr 20262:35 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSFinal Results
13th Apr 20261:31 pmRNSNotice of Investor Presentation
13th Apr 20261:29 pmRNSNotice of Results
31st Mar 20267:00 amRNSTotal Voting Rights
20th Mar 20264:17 pmRNSTotal Voting Rights
9th Mar 202612:36 pmRNS-REbiquity Appoints Head of Growth, Americas
6th Feb 202610:03 amRNS-REbiquity Strategic Leadership Appointment
22nd Jan 20267:00 amRNSTrading Update
24th Nov 202512:33 pmRNSTR-1: Notification of Major Holdings
21st Oct 20258:00 amRNS-REbiquity Joins Ad Context Protocol
15th Oct 20259:27 amRNSNotification of Major Holdings
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20251:22 pmRNS-RInvestor Presentation
1st Oct 20251:17 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSInterim Results
23rd Sep 20257:00 amRNSTrading Update
16th Sep 20257:00 amRNS-RNotice of Investor Presentation
2nd Sep 20257:00 amRNS-RLaunch of Advisory Board to Drive Strategic Growth
1st Sep 20257:00 amRNSBoard Changes
21st Aug 202511:53 amRNSNotification of Major Holdings
6th Aug 20258:30 amRNSTrading Update and Notice of Interim Results
29th Jul 202511:32 amRNSAllotment of Shares and Total Voting Rights
29th Jul 20259:22 amRNSBoard Appointments
24th Jun 20254:03 pmRNS-REbiquity Strengthens Americas Leadership
10th Jun 20257:00 amRNS-RAwarded Silver as a Top UK Media Consultancy
4th Jun 20255:24 pmRNSResult of AGM
22nd May 20257:00 amRNSDirector/PDMR Shareholding
2nd May 202511:59 amRNSAnnual Report and Notice of Annual General Meeting
22nd Apr 20257:00 amRNSFinal Results
10th Apr 20252:41 pmRNSNotice of Results
9th Apr 20257:00 amRNSNotification of major holdings
31st Mar 20254:33 pmRNSTotal Voting Rights
19th Mar 202510:00 amRNSHolding(s) in Company
19th Mar 202510:00 amRNSHolding(s) in Company
12th Mar 202510:46 amRNSIssue of Shares and TVR
3rd Mar 20257:00 amRNSAppointment of Chief Financial Officer
17th Feb 20257:00 amRNSAppointment of NOMAD and Trading Update
5th Dec 20247:00 amRNSTrading Update
19th Nov 20247:00 amRNSDirectorate Change
3rd Oct 20244:22 pmRNSTotal Voting Rights
30th Sep 20249:27 amRNSNotification of major holdings
26th Sep 20247:00 amRNSInterim Results
23rd Sep 20241:56 pmRNSNotification of major holdings
22nd Aug 202410:55 amRNSTrading Update and Notice of results
22nd Aug 20247:00 amRNSTrading Update and Notice of results
5th Aug 20247:00 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.